Alzheimer's disease and anaesthesia: Potential relationships and clinical implications;Maladie d'Alzheimer et anesthésie: relations potentielles et implications cliniques

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 1, 2011, Pages 37-46

  Andre D ^a   Dartigues, J F ^b   Sztark, F ^a  

^a HÔPITAL PELLEGRIN   (France)

^b INSERM   (France)

Author keywords

Alzheimer's disease; Anaesthetics neurotoxicity; Postoperative cognitive dysfunction

Indexed keywords

ANESTHETIC AGENT;

AGING; ALZHEIMER DISEASE; ANESTHESIOLOGICAL TECHNIQUES; COGNITIVE DEFECT; DEMENTIA; ELDERLY CARE; FAMILY HISTORY; HUMAN; MEDICAL HISTORY; NEUROLOGIC DISEASE; PERIOPERATIVE PERIOD; RISK FACTOR; SHORT SURVEY;

AGED; ALZHEIMER DISEASE; ANESTHESIA; ANESTHETICS; COGNITION DISORDERS; HUMANS; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 79551626248     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.10.013     Document Type: Short Survey

References (126)

1. Prince M. Epidemiology of dementia. Psychiatry 2007, 6:488-489.
2. Salloway S. Introduction: the prevalence of Alzheimer's disease - a growing crisis. CNS Spectr 2008, 13(Suppl 3):1.
3. Ruitenberg A., Ott A., Swieten J.C., Hofman A., Breteler M.M. Incidence of dementia: does gender make a difference?. Neurobiol Aging 2001, 22:575-580.
4. Mukaetova-Ladinska E., McKeith I. Delirium and dementia. Medicine 2004, 32:44-47.
5. Bone I., Rosen M. Alzheimer's disease and anaesthesia. Anaesthesia 2000, 55:592-593.
6. Collyer T.C., Frater R. Alzheimer's disease and anaesthesia. Br J Anaesth 2007, 98:692-693.
7. Bohnen N.I., Warner M.A., Kokmen E., Beard C.M., Kurland L.T. Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc 1994, 42:198-201.
8. Fodale V., Quattrone D., Trecroci C., Caminiti V., Santamaria L.B. Alzheimer's disease and anaesthesia: implications for the central cholinergic system. Br J Anaesth 2006, 97:445-452.
9. Culley D.J., Xie Z., Crosby G. General anesthetic-induced neurotoxicity: an emerging problem for the young and old?. Curr Opin Anaesthesiol 2007, 20:408-413.
10. Eckenhoff R.G., Johansson J.S., Wei H., Carnini A., Kang B., Wei W., et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004, 101:703-709.
11. Gasparini M., Vanacore N., Schiaffini C., Brusa L., Panella M., Talarico G., et al. A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci 2002, 23:11-14.
12. Kuehn B.M. Anesthesia-Alzheimer disease link probed. JAMA 2007, 297:1760.
13. Xie Z., Dong Y., Maeda U., Alfille P., Culley D.J., Crosby G., et al. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006, 104:988-994.
14. Xie Z., Dong Y., Maeda U., Moir R., Inouye S.K., Culley D.J., et al. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci 2006, 61:1300-1306.
15. Xie Z., Dong Y., Maeda U., Moir R.D., Xia W., Culley D.J., et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007, 27:1247-1254.
16. Zhang G., Dong Y., Zhang B., Ichinose F., Wu X., Culley D.J., et al. Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine. J Neurosci 2008, 28:4551-4560.
17. Delacoutre A, Campion D, Davous P. Maladie d'Alzheimer. EMC Neurol 2007;17-056-A-15.
18. Amieva H., Le Goff M., Millet X., Orgogozo J.M., Peres K., Barberger-Gateau P., et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008, 64:492-498.
19. Tanzi R.E. The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 2005, 8:977-979.
20. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
21. Xie Z., Tanzi R.E. Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol 2006, 41:346-359.
22. Woltjer R L, Milatovic D. Therapeutic uses of cholinesterase inhibitors in neurodegenerative diseases. In: Gupta RC, editor. Toxicology of Organophosphate & Carbamate Compounds. Elsevier Inc; 2006. p. 25-33.
23. McGeer P.L., McGeer E. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001, 22:799-809.
24. Dimopoulos N., Piperi C., Salonicioti A., Mitropoulos P., Kallai E., Liappas I., et al. Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population. Neurosci Lett 2006, 398:118-123.
25. Lopez J.R., Lyckman A. Oddo Sea. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem 2008, 105:262-271.
26. Arancio O., Chao M.V. Neurotrophins, synaptic plasticity and dementia. Curr Opin Neurobiol 2007, 17:325-330.
27. Abildstrom H., Christiansen M., Siersma V.D., Rasmussen L.S. Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology 2004, 101:855-861.
28. Leung J.M., Sands L.P., Wang Y., Poon A., Kwok P.Y., Kane J.P., et al. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology 2007, 107:406-411.
29. Salloway S., Gur T., Berzin T., Tavares R., Zipser B., Correia S., et al. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J Neurol Sci 2002, 203/204:183-187.
30. Ti L.K., Mathew J.P., Mackensen G.B., Grocott H.P., White W.D., Reves J.G., et al. Effect of apolipoprotein E genotype on cerebral autoregulation during cardiopulmonary bypass. Stroke 2001, 32:1514-1519.
31. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and the risk of dementia. Lancet 2000, 356:1627-1631.
32. Deane R., Sagare A., Hamm K., Parisi M., Lane S., Finn M.B., et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 2008, 118:4002-4013.
33. Biessels G.J., Kappelle L.J. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?. Biochem Soc Trans 2005, 33:1041-1044.
34. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
35. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 2005, 28:202-208.
36. Zlokovic B.V., Deane R., Sallstrom J., Chow N., Miano J.M. Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol 2005, 15:78-83.
37. Hanon O, Latour F, Seux M, Lenoir H, Forette F, Rigaud A. Relations entre la pression artérielle et les fonctions cognitives. Données du réseau sur la maladie d'Alzheimer Français (REAL.FR). Rev Med Interne 2003;24:292-300s.
38. Francis PT. Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 2003;18:S15-21.
39. Matthews K.L., Chen C.P., Esiri M.M., Keene J., Minger S.L., Francis P.T. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 2002, 51:407-416.
40. Bales K.R. Paroxetine administration decreases AD-like pathology and reverses memory impairments in a transgenic model of Alzheimer disease. Exp Neurol 2007, 207:1-3.
41. Nelson R.L., Guo Z., Halagappa V.M., Pearson M., Gray A.J., Matsuoka Y., et al. Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice. Exp Neurol 2007, 205:166-176.
42. Hanning C.D. Postoperative cognitive dysfunction. Br J Anaesth 2005, 95:82-87.
43. Pain L., Laalou F.Z. Fonctions cognitives après anesthésie. Presse Med 2009, 38:1597-1606.
44. Bekker A.Y., Weeks E.J. Cognitive function after anaesthesia in the elderly. Best Pract Res Clin Anaesthesiol 2003, 17:259-272.
45. Bokeriia L.A., Golukhova E.Z., Polunina A.G., Davydov D.M., Begachev A.V. Neural correlates of cognitive dysfunction after cardiac surgery. Brain Res Brain Res Rev 2005, 50:266-274.
46. Gao L., Taha R., Gauvin D., Othmen L.B., Wang Y., Blaise G. Postoperative cognitive dysfunction after cardiac surgery. Chest 2005, 128:3664-3670.
47. Johnson T., Monk T., Rasmussen L.S., Abildstrom H., Houx P., Korttila K., et al. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology 2002, 96:1351-1357.
48. Lee T.A., Wolozin B., Weiss K.B., Bednar M.M. Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005, 7:319-324.
49. Monk T.G., Weldon B.C., Garvan C.W., Dede D.E., van der Aa M.T., Heilman K.M., et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008, 108:18-30.
50. Newman M.F., Croughwell N.D., Blumenthal J.A., Lowry E., White W.D., Spillane W., et al. Predictors of cognitive decline after cardiac operation. Ann Thorac Surg 1995, 59:1326-1330.
51. Graham E.V., Ramesh L.P., David J. Chambers. Cardiopulmonary bypass: perioperative cerebral blood flow and postoperative dognitive deficit. Ann Thorac Surg 1995, 59:1331-1335.
52. Rasmussen L.S. Postoperative cognitive dysfunction: incidence and prevention. Best Pract Res Clin Anaesthesiol 2006, 20:315-330.
53. Kostopanagiotou G., Markantonis S.L., Polydorou M., Pandazi A., Kottis G. Recovery and cognitive function after fentanyl or remifentanil administration for carotid endarterectomy. J Clin Anesth 2005, 17:16-20.
54. Rasmussen L.S., Moller J.T. Cognitive dysfunction after anaesthesia. Curr Anaesth Crit Care 1998, 9:307-311.
55. Canet J., Raeder J., Rasmussen L.S., Enlund M., Kuipers H.M., Hanning C.D., et al. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiol Scand 2003, 47:1204-1210.
56. Fredman B., Noga J., Zohar E., Yaretzky A., Jedeikin R. Influence of thiopental and propofol on postoperative cognitive recovery in the elderly patient undergoing general anesthesia. J Clin Anesth 1999, 11:635-640.
57. Bekker A.Y., Berklayd P., Osborn I., Bloom M., Yarmush J., Turndorf H. The recovery of cognitive function after remifentanil-nitrous oxide anesthesia is faster than after an isoflurane-nitrous oxide-fentanyl combination in elderly patients. Anesth Analg 2000, 91:117-122.
58. Sarasin D.S., Ghoneim M.M., Block R.I. Effects of sedation with midazolam or propofol on cognition and psychomotor functions. J Oral Maxillofac Surg 1996, 54:1187-1193.
59. Rasmussen L.S., Larsen K., Houx P., Skovgaard L.T., Hanning C.D., Moller J.T. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand 2001, 45:275-289.
60. Abildstrom H., Rasmussen L.S., Rentowl P., Hanning C.D., Rasmussen H., Kristensen P.A., et al. Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand 2000, 44:1246-1251.
61. Cook D.J., Huston 3rd J., Trenerry M.R., Brown R.D., Zehr K.J., Sundt 3rd T.M. Postcardiac surgical cognitive impairment in the aged using diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2007, 83:1389-1395.
62. Ouattara A., Amour J., Bouzguenda H. Modifications des fonctions cognitives après chirurgie cardiaque. Presse Med 2009, 38:1607-1612.
63. Moller J.T., Cluitmans P., Rasmussen L.S., Houx P., Rasmussen H., Canet J., et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998, 351:857-861.
64. Rasmussen L.S., Johnson T., Kuipers H.M., Kristensen D., Siersma V.D., Vila P., et al. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand 2003, 47:260-266.
65. Hu Z., Ou Y., Duan K., Jiang X. Inflammation: a bridge between postoperative cognitive dysfunction and Alzheimer's disease. Med Hypoth 2010, 74:722-724.
66. Ghoneim M.M. Drugs and human memory (part 1): clinical, theoretical, and methodologic issues. Anesthesiology 2004, 100:987-1002.
67. Ghoneim M.M. Drugs and human memory (part 2). Clinical, theoretical, and methodologic issues. Anesthesiology 2004, 100:1277-1297.
68. Baranov D., Bickler P.E., Crosby G.J., Culley D.J., Eckenhoff M.F., Eckenhoff R.G., et al. Consensus Statement: First International Workshop on Anesthetics and Alzheimer's Disease. Anesth Analg 2009, 108:1627-1630.
69. Pratico C., Quattrone D., Lucanto T., Amato A., Penna O., Roscitano C., et al. Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium. Med Hypoth 2005, 65:972-982.
70. Harris R.A., Eger 2nd E.I. Alzheimer's disease and anesthesia: out of body, out of mind or not?. Ann Neurol 2008, 64:595-597.
71. Culley D.J, Baxter M.G., Yukhananov R., Crosby G. Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology 2004, 100:309-314.
72. Culley D.J., Baxter M.G., Crosby C.A., Yukhananov R., Crosby G. Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane-nitrous oxide anesthesia in aged rats. Anesth Analg 2004, 99:1393-1397.
73. Culley D.J., Yukhananov R.Y., Xie Z., Gali R.R., Tanzi R.E., Crosby G. Altered hippocampal gene expression 2 days after general anesthesia in rats. Eur J Pharmacol 2006, 549:71-78.
74. Bianchi S.L., Tran T., Liu C.L. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 2008, 29:1002-1010.
75. Planel E., Richter K.E., Nola C.E., JFinley J.E. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatases activity by hypothermia. J Neurosci 2007, 27:3090-3097.
76. Ikeda Y., Ishiguro K., Fujita S.C. Ether stress-induced Alzheimer-like tau phosphorylation in the normal mouse brain. FEBS Lett 2007, 581:891-897.
77. Planel E., Bretteville A., Liu L. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J 2009, 23:2595-2604.
78. Wei H., Liang G., Yang H. Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 2007, 425:59-62.
79. Jevtovic-Todorovic V., Hartman R.E. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003, 23:876-882.
80. Ma D., Williamson P., Januszewski A., Nogaro M.C. Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007, 106:746-753.
81. Mandal P.K., Pettegrew J.W., McKeag D.W., Mandal R. Alzheimer's disease: halothane induces Abeta peptide to oligomeric form-solution NMR studies. Neurochem Res 2006, 31:883-890.
82. Mandal P.K., Fodale V., Isoflurane desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochem Biophys Res Commun 2009, 379:716-720.
83. Zhang B., Dong Y., Zhang G., Moir R., Xia W., Yue Y. The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. J BIiol Chem 2008, 283:11866-11875.
84. Zhang X., Zhou K., Cui J., et al. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 2007, 282:10873-10880.
85. Kvolik S., Glavas-Obrovac L., Bares V., Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005, 77:2369-2383.
86. Loop T., Dovi-Akue D., Frick M., Roesslein M., Egger L., Humar M., et al. Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology 2005, 102:1147-1157.
87. Wei H., Kang B., Wei W., Liang G., Meng Q.C., Li Y., et al. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005, 1037:139-147.
88. Matsuoka H., Kurosawa S., Horinouchi T., Kato M., Hashimoto Y. Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology 2001, 95:1467-1472.
89. Zaugg M., Jamali N.Z., Lucchinetti E., Shafiq S.A., Siddiqui M.A. Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. Anesthesiology 2000, 93:209-218.
90. Tyther R., Fanning N., Halligan M., Wang J., Redmond H.P., Shorten G. The effect of the anaesthetic agent isoflurane on the rate of neutrophil apoptosis in vitro. Ir J Med Sci 2001, 170:41-44.
91. Wise-Faberowski L., Raizada M.K., Sumners C. Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth Analg 2001, 93:1281-1287.
92. Wise-Faberowski L., Aono M., Pearlstein R.D., Warner D.S. Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity. Anesth Analg 2004, 99:1708-1714.
93. de Klaver M.J., Manning L., Palmer L.A., Rich G.F. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. Anesthesiology 2002, 97:24-32.
94. Kawaguchi M., Drummond J.C., Cole D.J., Kelly P.J., Spurlock M.P., Patel P.M. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg 2004, 98:798-805.
95. Gray J.J., Bickler P.E., Fahlman C.S., Zhan X., Schuyler J.A. Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology 2005, 102:606-615.
96. Wei H., Liang G., Yang H., Wang Q., Hawkins B., Madesh M., et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology 2008, 108:251-260.
97. Liang G., Wang Q., Li Y., Kang B., Eckenhoff M.F., Eckenhoff R.G., et al. A presenilin-1 mutation renders neurons vulnerabale to isoflurane toxicity. Anesth Analg 2008, 106:492-500.
98. Wei H., Xie Z. Anesthesia, calcium homeostasis and Alzheimer's disease. Curr Alzheimer Res 2009, 6:30-35.
99. Bickler P.E., Fahlman C.S. The inhaled anesthetic, isoflurane, enhances Ca2+-dependent survival signaling in cortical neurons and modulates MAP kinases, apoptosis proteins and transcription factors during hypoxia. Anesth Analg 2006, 103:419-429.
100. Bickler P.E., Zhan X., Fahlman C.S. Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 2005, 103:532-539.
101. Zheng S., Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003, 118:99-106.
102. Zuo Z., Wang Y., Huang Y. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway. Eur J Pharmacol 2006, 542:84-91.
103. Bekker A.R., Shah R., Quartermain D., Li Y.S., Blanck T. Isoflurane preserves spatial working memory in adult mice after moderate hypoxia. Anesth Analg 2006, 102:1134-1138.
104. Sigaut S., Jannier V., Rouelle D., Gressens P., Mantz J., Damani S. The preconditioning effect of sevoflurane on the oxygen glucose-deprived hippocampal slice: the role of tyrosine kinases and duration of ischemia. Anesth Analg 2009, 108:601-608.
105. Degos V., Teissier N., Gressens P., Puybasset L., Mantz J. Inflammation et lésions cérébrales aiguës en anesthséie rénimation. Ann Fr Anesth Reanim 2008, 27:1008-1015.
106. Palotas M., Palotas A., Bjelik A., Pakaski M., Hugyecz M., Janka Z., et al. Effect of general anesthetics on amyloid precursor protein and mRNA levels in the rat brain. Neurochem Res 2005, 30:1021-1026.
107. Kalman J., Palotas M., Pakaski M., Hugyecz M., Janka Z., Palotas A. Unchanged rat brain amyloid precursor protein levels after exposure to benzodiazepines in vivo. Eur J Anaesthesiol 2006, 23:772-775.
108. Kotermanski S.E., Johansson J.W. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. J Neurosci 2009, 29:2774-2779.
109. Johnson J.W., Kotermanski S.E. Mechanism of action of memantine. Curr Opin Pharmacol 2006, 6:61-67.
110. Bohnen N., Warner M.A., Kokmen E., Kurland L.T. Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. Int J Neurosci 1994, 77:181-185.
111. Stone P., Doherty P. Anaesthesia for elderly patients. Anaesth Intensive Care 2007, 8:361-364.
112. Prough D.S. Anesthetic pitfalls in the elderly patient. J Am Coll Surg 2005, 200:784-794.
113. Pancrazi M.P., Metais P. Maladie d'Alzheimer, traitement des troubles psychologiques et comportementaux. Presse Med 2005, 34:667-672.
114. Fernandez C.R., Fields A., Richards T., Kaye A.D. Anesthetic considerations in patients with Alzheimer's disease. J Clin Anesth 2003, 15:52-58.
115. Taylor M., Grant F. Cognitive dysfunction in the elderly. Why assessment is of practical consequence to anaesthsists. Curr Anaesth Crit Care 2002, 13:221-227.
116. Jacovaa C., Kerteszb A., Blairb M., Fiskc J., Feldmana H. Neuropsychological testing and assessment for dementia. Alzheimers Dement 2007, 3:299-317.
117. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
118. O'Rourke N., Tuokko H., Hayden S., Lynn Beattie B. Early identification of dementia: predictive validity of the clock test. Arch Clin Neuropsychol 1997, 12:257-267.
119. Solomon P.R., Hirschoff A., Kelly B., Relin M., Brush M., DeVeaux R.D., et al. A 7minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 1998, 55:349-355.
120. Heyn P., Abreu B.C., Ottenbacher K.J. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004, 85:1694-1704.
121. Talassi E., Guerreschi M., Feriani M., Fedi V., Bianchetti A., Trabucchi M. Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr 2007, 44 Suppl 1::391-399.
122. Durand E., Pradat-Diehl P., Poncet F., Renaud A. Evolution d'une démence frontotemporale en rééducation. Ann Réadaptation Méd Phys 2000, 43:125-131.
123. Cooper C., Katona C., Orrell M., Livingston G. Coping strategies and anxiety in caregivers of people with Alzheimer's disease: the LASER-AD study. J Affect Disord 2006, 90:15-20.
124. Cooper C., Katona C., Orrell M., Livingston G. Coping strategies, anxiety and depression in caregivers of people with Alzheimer's disease. Int J Geriatr Psychiatry 2008, 23:929-936.
125. Salloway S., Mintzer J., Weiner M.F., Cummings J.L. Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement 2008, 4:65-79.
126. Leclerc C., Genuit-Leclerc L., Citerne O. Bradycardie liée à la galantamine. Ann Fr Anesth Reanim 2008, 27:949-952.